Silly be sold most at 2$ thinking thats a reasonable price.. but up up up.. My concern is always market share.. smsf are growing.. but its real growth is limited compared to a xero/myob who target is SME.. .
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game